The forecasted production values for blood-grouping reagents in France indicate a declining trend from 2024 to 2028, dropping from 30.552 million Euros to 25.831 million Euros. The year-on-year decrease shows an average decline in production value of approximately 3.4% annually. The compound annual growth rate (CAGR) for this period anticipates a steady reduction, averaging around 2.9% each year.
Key future trends to watch for include advancements in technology that may alter production efficiency, changes in healthcare policies affecting demand, and potential competition from alternative solutions. Monitoring these factors will be crucial in understanding the long-term market dynamics for blood-grouping reagents.
